Document Type

Article

Publication Date

5-6-2024

Comments

This article is the author’s final published version in Current Obstetrics and Gynecology Reports, Volume 13, 2024, Pages 144-153.

The published version is available at https://doi.org/10.1007/s13669-024-00387-w. Copyright © The Author(s) 2024.

Publication made possible in part by support through a transformative agreement between Thomas Jefferson University and the publisher.

Abstract

Purpose of Review This review outlines the current evidence on the contraceptive and menstrual management methods that are used for transmasculine or gender-diverse (TGD) individuals, as well as the gaps in the literature for this population.

Recent Findings Contraception and menstrual management continue to be an understudied area in the care of TGD individuals, with much of existing research extrapolated from cisgender populations. Emerging studies have looked at contraceptive and menstrual management choices and outcomes in adolescents and highlight the 52 mg LNG-IUD as an option that is efficacious for both indications, as well as high-dose progestin-only pills for menstrual suppression only.

Summary The best method for contraception and menstrual management is the one a patient feels most comfortable using. Clinicians should work to understand the nuances and interplay of pregnancy prevention, menstruation, and gender dysphoria in TGD patients to help them achieve their goals. Further research on these topics that focus on TGD populations is needed to better drive current recommendations and guidelines in supporting a vulnerable population.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English

Download

Share

COinS